Preview

Медицинский алфавит

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Доступ платный или только для Подписчиков

Лекарственные препараты, прием которых ассоциирован с развитием лекарственно-индуцированного панкреатита: фокус на редко обсуждаемые классы препаратов

https://doi.org/10.33667/2078-5631-2021-29-33-39

Полный текст:

Аннотация

Более 500 лекарственных средств внесены в базу Всемирной организации здравоохранения как препараты, способные вызвать острое воспаление поджелудочной железы. Лекарственно-индуцированный острый панкреатит развивается на фоне приема многих лекарственных средств (статины, противоопухолевые препараты, препараты для лечения заболеваний желудочно-кишечного тракта, анальгетики и противовоспалительные средства, противомикробные, противопаразитарные и противовирусные препараты, препараты для лечения туберкулеза, заболеваний центральной нервной системы, эстрогены, препараты кальция и др.), относящихся к разным классам, при этом клиническая картина не отличается от панкреатита другой этиологии. На основании этого стоит обращать внимание на причины, которые способствовали развитию данной патологии. Поэтому одним из основных принципов диагностики лекарственно-индуцированного панкреатита является тщательный сбор фармакологического анамнеза. При подозрении, что панкреатит был вызван лекарственным средством, следует немедленно прекратить его использование и приступить к традиционному терапевтическому лечению.

Об авторах

А. В. Филиппова
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия

Филиппова Анастасия Витальевна, ординатор кафедры терапии и полиморбидной патологии

Москва



Е. Е. Павлеева
ФГБОУ ВО «Московский государственный медико-стоматологический университет имени А.И. Евдокимова» Минздрава России
Россия

Павлеева Елена Евгеньевна, к.м.н., ассистент кафедры пропедевтики внутренних болезней и гастроэнтерологии

Москва



О. Д. Остроумова
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)
Россия

Остроумова Ольга Дмитриевна, д.м.н., проф., зав. кафедрой терапии и полиморбидной патологии; проф. кафедры клинической фармакологии и пропедевтики внутренних болезней

eLibrary SPIN: 3910–6585

Москва



Список литературы

1. Eland IA, van Puijenbroek EP, Sturkenboom MJCM, Wilson JHP, Stricker BH. Drug-Associated Acute Pancreatitis: Twenty-One Years of Spontaneous Reporting in The Netherlands. American Journal of Gastroenterology. 1999; 94 (9): 2417–2422. DOI: 10.1111/j.1572–0241.1999.01367.x.

2. Dolin R, Lambert JS, Morse GD, Reichman RC et al. 2′,3′-Dideoxyinosine in Patients with AIDS or AIDS-Related Complex. Reviews of Infectious Diseases. 1990; 12 (5): 540–551. DOI: 10.1093/clinids/12.Supplement_5.S540.

3. Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute Phase I study of 2’,3’-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles. Rev Infect Dis. 1990; 12 (5): 522–33. DOI: 10.1093/clinids/12.supplement_5.s522.

4. Wolfe D, Kanji S, Yazdi F et al. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations. PLoS One. 2020; 15 (4): e0231883. DOI: 10.1371/journal.pone.0231883.

5. NIAID updates dideoxyinosine toxicity profile, suggests ways to reduce risk of pancreatitis. Clin Pharm. 1990; 9 (11): 832, 838. DOI: 10.2165/00128413–199007540–00015.

6. Youssef SS, Iskandar SB, Scruggs J, Roy TM. Acute pancreatitis associated with omeprazole. Int J Clin Pharmacol Ther. 2005; 43 (12): 558–61. DOI: 10.5414/cpp43558.

7. Das S, Ganguly A, Ghosh A, Mondal S, Dey JK, Saha I. Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. Ther Drug Monit. 2012; 34 (3): 242–4. DOI: 10.1097/FTD.0b013e3182526e6a.

8. Murtaza G, Khalid MF, Mungo NA. Recurrent Pantoprazole-Associated Pancreatitis. Am J Ther. 2018; 25 (4): 492–493. DOI: 10.1097/MJT.0000000000000567.

9. Ocal S, Korkmaz M, Yıldırım AE, Altun R, Akbaş E, Selçuk H. Lansoprazole-induced acute pancreatitis. Turk J Gastroenterol. 2014; 25 (5): 582–3. DOI: 10.5152/tjg.2014.5117. 10. Eland IA, Alvarez CH, Stricker BH, Rodríguez LA. The risk of acute pancreatitis associated with acid-suppressing drugs. Br J Clin Pharmacol. 2000; 49 (5): 473–8. DOI: 10.1046/j.1365–2125.2000.00196.x.

10. Block MB, Genant HK, Kirsner JB. Pancreatitis as an adverse reaction to salicylazosulfapyridine. N Engl J Med. 1970; 282 (7): 380–2. DOI: 10.1056/NEJM197002122820710.

11. Chiba M, Horie Y, Ishida H, Arakawa H, Masamune O. A case of salicylazosulfapyridine (salazopyrin)-induced acute pancreatitis with positive Lymphocyte stimulation test (LST). Gastroenterol Jpn. 1987: 22 (2): 228–233. DOI: 10.1007/BF02774222.

12. Brazer SR, Medoff JR. Sulfonamide-induced pancreatitis. Pancreas. 1988; 3 (5): 583–6. DOI: 10.1097/00006676–198810000–00013.

13. Rubin R. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis. Am J Gastroenterol. 1994; 89 (5): 789–91. PMID: 7909645.

14. Garau P, Orenstein SR, Neigut DA, Kocoshis SA. Pancreatitis associated with olsalazine and sulfasalazine in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 1994; 18 (4): 481–5. DOI: 10.1097/00005176–199405000–00015.

15. Sachedina B. Acute Pancreatitis Due to 5-Aminosalicylate. Annals of Internal Medicine. 1989; 110 (6): 490. DOI: 10.7326/0003–4819–110–6–490.

16. Isaacs KL, Murphy D. Pancreatitis after rectal administration of 5-aminosalicylic acid. J Clin Gastroenterol. 1990; 12 (2): 198–9. DOI: 10.1097/00004836–199004000–00019.

17. Erdkamp F, Houben M, Ackerman E, Breed W, van Spreeuwel J. Pancreatitis induced by mesalamine. Neth J Med. 1992; 41 (1–2): 71–3. PMID: 1407243.

18. Radke M, Bartolomaeus G, Müller M, Richter I. Acute pancreatitis in Crohn’s disease due to 5-ASA therapy. J Pediatr Gastroenterol Nutr. 1993; 16 (3): 337–9. DOI: 10.1097/00005176–199304000–00022.

19. Abdullah AM, Scott RB, Martin SR. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis. J Pediatr Gastroenterol Nutr. 1993; 17 (4): 441–4. DOI: 1097/00005176–199311000–00019.

20. Fernández J, Sala M, Panés J, Feu F, Navarro S, Terés J. Acute pancreatitis after long-term 5-aminosalicylic acid therapy. Am J Gastroenterol. 1997; 92 (12): 2302–3. PMID: 9399776.

21. Adachi E, Okazaki K, Matsushima Y et al. Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis. Int J Pancreatol. 1999; 25 (3): 217–21. DOI: 10.1007/BF02925970.

22. Paul AC, Oommen SP, Angami S, Moses PD. Acute pancreatitis in a child with idiopathic ulcerative colitis on long-term 5-aminosalicylic acid therapy. Indian J Gastroenterol. 2000; 19 (4): 195–6. PMID: 11059196.

23. Ouakaa-Kchaou A, Gargouri D, Kochlef A, Bibani N, Elloumi H, Trad D, Kharrat J. Acute pancreatitis secondary to long-term 5- aminosalicylic acid therapy in a patient with ulcerative colitis: a case-report. Tunis Med. 2014; 92 (6): 423. PMID: 25741849.

24. Munk EM, Pedersen L, Floyd A, Nørgård B, Rasmussen HH, Sørensen HT. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study. Am J Gastroenterol. 2004; 99 (5): 884–8. DOI: 10.1111/j.1572–0241.2004.04123.x.

25. Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002; 51 (4): 536–9. DOI: 10.1136/gut.51.4.536.

26. Tran K, Froguel E, Jian R, Lemann M, Modigliani R. Acute pancreatitis induced by mesalazine. J Clin Gastroenterol. 1991; 13 (6): 715–6. DOI: 10.1097/00004836–199112000–00021.

27. Urbanek K, Vinklerova I, Krystynik O, Prochazk V. Acute Pancreatitis Induced by Drugs. 2012. DOI: 10.5772/25876.

28. Debongnie JC, Dekoninck X. Sulfasalazine, 5-ASA and acute pancreatitis in Crohn’s disease. J Clin Gastroenterol. 1994; 19 (4): 348–9. DOI: 10.1097/00004836–199412000–00024.

29. Lerche A, Vyberg M, Kirkegaard E. Acute cholangitis and pancreatitis associated with sulindac (clinoril). Histopathology. 1987; 11 (6): 647–53. DOI: 10.1111/j.1365–2559.1987.tb02675.x.

30. Nakashima Y, Howard JM. Drug-induced acute pancreatitis. Surg Gynecol Obstet. 1977; 145 (1): 105–9. PMID: 195355.

31. Khanna S, Kumar A. Acute pancreatitis due to hydrocortisone in a patient with ulcerative colitis. J Gastroenterol Hepatol. 2003; 18 (9): 1110–1. DOI: 10.1046/j.1440–1746.2003.03129.x.

32. Ungprasert P, Permpalung N, Summachiwakij S, Manatsathit W. A case of recurrent acute pancreatitis due to intra-articular corticosteroid injection. JOP. 2014; 15 (2): 208–9. DOI: 10.6092/1590–8577/2214.

33. Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013; 173 (6): 444–9. DOI: 10.1001/jamainternmed.2013.2737.

34. Kimura T, Zuidema GD, Cameron JL. Steroid administration and acute pancreatitis: studies with an isolated, perfused canine pancreas. Surgery. 1979; 85 (5): 520–4. PMID: 432812.

35. Dreiling DA, Janowitz HD, Rolbin H. Effect of ACTH and adrenocortical steroids on external pancreatic secretion in man. N Engl J Med. 1958; 258 (12): 603–5. DOI: 10.1056/NEJM195803202581207.

36. Hastier P, Buckley MJ, Peten EP et al. A new source of drug-induced acute pancreatitis: codeine. Am J Gastroenterol. 2000; 95 (11): 3295–8. DOI: 10.1111/j.1572–0241.2000.03213.x.

37. Gross JB, Comfort MW, Mathieson DR, Power MH. Elevated values for serum amylase and lipase following the administration of opiates: a preliminary report. Proc Staff Meet Mayo Clin. 1951; 26 (5): 81–7. PMID: 14808448.

38. Tisdale JE, Miller DA. Drug-induced Diseases: Prevention, Detection, and Management. American Society of Health-System Pharmacists; 2018; с. 877–904.

39. Memon AN. Pancreatitis and sulindac. Ann Intern Med. 1982; 97 (1): 139. DOI: 10.7326/0003–4819–97–1–139_1.

40. Zygmunt DJ, Williams HJ, Bienz SR. Acute pancreatitis associated with long-term sulindac therapy. West J Med. 1986; 144 (4): 461–2. PMID: 3716404.

41. Ksiądzyna D. Drug-induced acute pancreatitis related to medications commonly used in gastroenterology. Eur J Intern Med. 2011; 22 (1): 20–5. DOI: 10.1016/j.ejim.2010.09.004.

42. Jick H, Derby LE, García Rodríguez LA, Jick SS, Dean AD. Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study. Pharmacotherapy. 1993; 13 (3): 212–7. PMID: 8321735.

43. Trapani G, Latrofa A, Franco M et al. Propofol analogues. Synthesis, relationships between structure and affinity at GABAA receptor in rat brain, and differential electrophysiological profile at recombinant human GABAA receptors. J Med Chem. 1998; 41 (11): 1846–54. DOI: 10.1021/jm970681h.

44. Krasowski MD, Jenkins A, Flood P, Kung AY, Hopfinger AJ, Harrison NL. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. J Pharmacol Exp Ther. 2001; 297 (1): 338–51. PMID: 11259561.

45. Krasowski MD, Hong X, Hopfinger AJ, Harrison NL. 4D-QSAR analysis of a set of propofol analogues: mapping binding sites for an anesthetic phenol on the GABA(A) receptor. J Med Chem. 2002; 45 (15): 3210–21. DOI: 10.1021/jm010461a.

46. Ljung R, Lagergren J, Bexelius TS, Mattsson F, Lindblad M. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study. Gut. 2012 Jun; 61 (6): 873–6. DOI: 10.1136/gutjnl-2011–300949.

47. Hung WY, Kogelman L, Volpe G, Iafrati M, Davidson L. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009; 34 (5): 486–9. DOI: 10.1016/j.ijantimicag.2009.05.004.

48. Marshall R. Tigecycline-induced pancreatitis. I Int J Antimicrob Agents. 2009; 44 (3): 239–41. DOI: 10.1310/hpj4403–239.

49. Steinberg WM. Acute drug and toxin induced pancreatitis. Hosp Pract (Off Ed). 1985; 20 (5): 95–102. DOI: 10.1080/21548331.1985.11703057.

50. Boudreaux JP, Hayes DH, Mizrahi S, Hussey J, Regenstein F, Balart L. Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity. Transplant Proc. 1993; 25 (2): 1873. PMID: 8470208.

51. Boyle MP. Minocycline-induced pancreatitis in cystic fibrosis. Chest. 2001; 119 (4): 1283–5. DOI: 10.1378/chest.119.4.1283.

52. Ocal S, Selcuk H, Korkmaz M, Unal H, Yilmaz U. Acute pancreatitis following doxycycline and ornidazole coadministration. JOP. 2010; 11 (6): 614–6. DOI: https://doi.org/10.6092/1590–8577/3408.

53. Wachira JK, Jensen CH, Rhone K. Doxycycline-induced pancreatitis: a rare finding. S D Med. 2013; 66 (6): 227–9. PMID: 23923680.

54. Gilson M, Moachon L, Jeanne L et al. Acute pancreatitis related to tigecycline: case report and review of the literature. Scand J Infect Dis. 2008; 40 (8): 681–3. DOI: 10.1080/00365540801938949.

55. Lipshitz J, Kruh J, Cheung P, Cassagnol M. Tigecycline-induced pancreatitis. J Clin Gastroenterol. 2009; 43 (1): 93. DOI: 10.1097/MCG.0b013e318164939c.

56. Hung WY, Kogelman L, Volpe G, Iafrati M, Davidson L. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009; 34 (5): 486–9. DOI: 10.1016/j.ijantimicag.2009.05.004.

57. Marshall R. Tigecycline-induced pancreatitis. I Int Antimicrob Agents. 2009; 44 (3): 239–41. DOI: 10.1310/hpj4403–239.

58. Prot-Labarthe S. Youdaren R. Benkerrou M. et al. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J. 2010; 29 (9): 890–1. DOI: 10.1097/inf.0b013e3181e83a85.

59. Okon E, Engell C, van Manen R, Brown J. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports. Pharmacotherapy. 2013; 33 (1): 63–8. DOI: 10.1002/phar.1159.

60. Hanline MH Jr. Acute pancreatitis caused by ampicillin. South Med J. 1987; 80 (8): 1069. DOI: 10.1097/00007611–198708000–00049.

61. Mann S, Thillainayagam A. Is ciprofloxacin a new cause of acute pancreatitis? J Clin Gastroenterol. 2000; 31 (4): 336. DOI: 10.1097/00004836–200012000–00014.

62. Sung HY, Kim JI, Lee HJ et al. Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. Gut Liver. 2014; 8 (3): 265–70. DOI: 10.5009/gnl.2014.8.3.265.

63. Barrett PV, Thier SO. Meningitis and pancreatitis associated with sulfamethizole. N Engl Med. 1963; 268 (1): 36-–7. DOI: 10.1056/NEJM196301032680109.

64. Plotnick BH, Cohen I, Tsang T, Cullinane T. Metronidazole-induced pancreatitis. Ann Intern Med. 1985; 103 (6) (Pt 1): 891–2. DOI: 10.7326/0003–4819–103–6–891.

65. Sanford KA, Mayle JE, Dean HA, Greenbaum DS. Metronidazole associated pancreatitis. Ann Intern Med. 1988; DOI: 109: 756–7.

66. Celifarco A, Warschauer C, Burakoff R. Metronidazole-induced pancreatitis. Am J Gastroenterol. 1989; 84 (8): 958–60. PMID: 2756988.

67. Corey WA, Doebbeling BN, DeJong KJ, Britigan BE. Metronidazole-induced acute pancreatitis. Rev Infect Dis. 1991; 13 (6): 1213–5. DOI: 10.1093/clinids/13.6.1213.

68. Sura ME, Heinrich KA, Suseno M. Metronidazole-associated pancreatitis. Ann Pharmacother. 2000; 34 (10): 1152–5. DOI: 10.1345/aph.10021.

69. Feola DJ, Thornton AC. Metronidazole-induced pancreatitis in a patient with recurrent vaginal trichomoniasis. Pharmacotherapy. 2002; 22 (11): 1508–10. DOI: 10.1592/phco.22.16.1508.33691.

70. Nigwekar SU, Casey KJ. Metronidazole-induced pancreatitis. A case report and review of literature. JOP. 2004; 5 (6): 516–9. PMID: 15536294.

71. O’Halloran E, Hogan A, Mealy K. Metronidazole-induced pancreatitis. HPB Surg. 2010; 2010: 1–4. DOI: 10.1155/2010/523468.

72. Murphey SA, Josephs AS. Acute Pancreatitis Associated With Pentamidine Therapy. Arch Intern Med. 1981; 141 (1): 56–58. DOI: 10.1001/archinte.1981.00340010052013.

73. Salmeron S, Petitpretz P, Katlama C, Herve P, Brivet F, Simonneau G, Duroux P, Regnier B. Pentamidine and pancreatitis. Ann Intern Med. 1986; 105 (1): 140–1. DOI: 10.7326/0003–4819–105–1–140_2.

74. Zuger A, Wolf BZ, el-Sadr W, Simberkoff MS, Rahal JJ. Pentamidine-associated fatal acute pancreatitis. JAMA. 1986; 256 (17): 2383–5. PMID: 3490588.

75. Herer B, Chinet T, Labrune S, Collignon MA, Chretien J, Huchon G. Pancreatitis associated with pentamidine by aerosol. BMJ. 1989; 298 (6673): 605. DOI: 10.1136/bmj.298.6673.605-a.

76. Kumar S, Schnadig VJ, MacGregor MG. Fatal acute pancreatitis associated with pentamidine therapy. Am J Gastroenterol. 1989; 84 (4): 451–3. PMID: 2784622.

77. Schwartz MS, Cappell MS. Pentamidine-associated pancreatitis. Dig Dis Sci. 1989; 34 (10): 1617–20. DOI: 10.1007/BF01537122.

78. Hart CC. Aerosolized pentamidine and pancreatitis. Ann Intern Med. 1989; 111 (8): 691. DOI: 10.7326/0003–4819–111–8–691_1.

79. Pauwels A, Eliaszewicz M, Larrey D, Lacassin F, Poirier JM, Meyohas MC, Frottier J. Pentamidine-induced acute pancreatitis in a patient with AIDS. J Clin Gastroenterol. 1990; 12 (4): 457–9. DOI: 10.1097/00004836–199008000–00022.

80. O’Neil MG, Selub SE, Hak LJ. Pancreatitis during pentamidine therapy in patients with AIDS. Clin Pharm. 1991; 10 (1): 56–9. PMID: 1999087.

81. Wood G, Wetzig N, Hogan P, Whitby M. Survival from pentamidine induced pancreatitis and diabetes mellitus. Aust NZJ Med. 1991; 21 (3): 341–2. DOI: 10.1111/j.1445–5994.1991.tb04702.x.

82. Villamil A, Hammer RA, Rodriguez FH. Edematous pancreatitis associated with intravenous pentamidine. South Med J. 1991; 84 (6): 796–8. PMID: 2052980.

83. Millard PS, van der Horst C. Reversible diabetes mellitus after intravenous pentamidine. Am J Med. 1991; 91 (4): 442. DOI: 10.1016/0002–9343(91)90169-x.

84. Klatt EC. Pathology of pentamidine-induced pancreatitis. Arch Pathol Lab Med. 1992; 116 (2): 162–4. PMID: 1733411.

85. Sauleda J, Gea JG, Aguar MC, Aran X, Pastó M, Broquetas JM. Probable pentamidine-induced acute pancreatitis. Ann Pharmacother. 1994; 28 (1): 52–3. DOI: 10.1177/106002809402800111.

86. Foisy MM, Slayter KL, Hewitt RG, Morse GD. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. Ann Pharmacother. 1994; 28 (9): 1025–8. DOI: 10.1177/106002809402800905.

87. Singh G, el-Gadi SM, Sparks RA. Pancreatitis associated with aerosolised pentamidine. Genitourin Med. 1995; 71 (2): 130–1. DOI: 10.1136/sti.71.2.130.

88. Murphy RL, Noskin GA, Ehrenpreis ED. Acute pancreatitis associated with aerosolized pentamidine. Am J Med. 1990 May; 88 (5N): 53N-56N. PMID: 2368775.

89. Yi PH, Veltre DR, Kuttab JS, Rangan V, Norton L. Acute groove pancreatitis due to isoniazid. Neth J Med. 2013 Mar; 71 (2): 104. PMID: 23462062.

90. Mattioni S, Zamy M, Mechai F, Raynaud JJ, Chabrol A, Aflalo V, Biour M, Bouchaud O. Isoniazid-induced recurrent pancreatitis. JOP. 2012; 13 (3): 314–6. PMID: 22572141.

91. Pandey AS, Surana A. Isoniazid-induced recurrent acute pancreatitis. Trop Doct. 2011; 41 (4): 249–50. DOI: 10.1258/td.2011.110127.

92. Rabassa AA, Trey G, Shukla U, Samo T, Anand BS. Isoniazid-induced acute pancreatitis. Ann Intern Med. 1994; 121 (6): 433–4. DOI: 10.7326/0003–4819–121–6–199409150–00007.

93. Stephenson I, Wiselka MJ, Qualie MJ. Acute pancreatitis induced by isoniazid in the treatment of tuberculosis. Am J Gastroenterol. 2001; 96 (7): 2271–2. DOI: 10.1111/j.1572–0241.2001.03984.x.

94. Chan KL, Chan HS, Lui SF, Lai KN. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis. 1994; 75 (5): 383–5. DOI: 10.1016/0962–8479(94)90086–8.

95. Chow KM, Szeto CC, Leung CB, Li PK. Recurrent acute pancreatitis after isoniazid. Neth J Med. 2004; 62 (5): 172–4. PMID: 15366703.

96. Kvale PA, Parks RD. Letter: Acute abdomen. An unusual reaction to isoniazid. Chest. 1975; 68 (2): 271–2. DOI: 10.1378/chest.68.2.271a.

97. Jin CF, Sable R. Isoniazid-induced acute hepatitis and acute pancreatitis in a patient during chemoprophylaxis. J Clin Gastroenterol. 2002; 35 (1): 100–1. DOI: 10.1097/00004836–200207000–00024.

98. Saleem AF, Arbab S, Naz FQ. Isoniazid induced acute pancreatitis in a young girl. J Coll Physicians Surg Pak. 2015; 25 (4): 299–300. PMID: 25899200.

99. Izzedine H, Launay-Vacher V, Storme T, Deray G. Acute pancreatitis induced by isoniazid. Am J Gastroenterol. 2001; 96 (11): 3208–9. DOI: 10.1111/j.1572–0241.2001.05288.x.

100. Dickson I. Acute pancreatitis following administration of isoniatinic acid hydrazide; report of a case. Br J Tuberc Dis Chest. 1994; 50 (3): 277–8. DOI: 10.1016/s0366–0869(56)80036–1.

101. Chow KM, Szeto CC, Leung CB, Li PK. Recurrent acute pancreatitis after isoniazid. Neth J Med. 2004; 62 (5): 172–4. PMID: 15366703.

102. Chan KL, Chan HS, Lui SF, Lai KN. Recurrent acute pancreatitis induced by isoniazid. Tuber Lung Dis. 1994; 75 (5): 383–5. DOI: 10.1016/0962–8479(94)90086–8.

103. Chaudhari S, Park J, Anand BS, Pimstone NR, Dieterich DT, Batash S, Bini EJ. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci. 2004; 49 (6): 1000–6. DOI: 10.1023/b: ddas.0000034562.17003.50.

104. Cechi E, Forte P, Cini E, Banchelli G, Ferlito C, Mugelli A. Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C. Emerg Med Australas 2004; 16 (5–6): 473–5. DOI: 10.1111/j.1742–6723.2004.00653.x.

105. Weber A, Carbonnel F, Simon N et al. Severe acute pancreatitis related to the use of adefovir in a liver transplant recipient. Gastroenterol Clin Biol. 2008; 32 (2): 247–249 DOI: 10.1016/j.gcb.2008.01.028.

106. Di Martino V, Ezenfis J, Benhamou Y et al. Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge. AIDS Lond Engl. 1999; 13 (11): 1421–1423. DOI: 10.1097/00002030–199907300–00028.

107. Bilar JM, Carvalho-Filho RJ, Mota CFMGP, Fucuta P da S, Ferraz MLCG. Acute pancreatitis associated with boceprevir: a case report. Braz J Infect Dis Off Publ Braz Soc Infect Dis. 2014; 18 (4): 454–456. DOI: 10.1016/j.bjid.2014.03.008.

108. Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007; 48 (7): 1223–44. DOI: 10.1111/j.1528–1167.2007.01041.x.

109. Laczek JT, Shrestha M, Kortan ND, Lake JM. Carbamazepine-induced pancreatitis with positive rechallenge. J Clin Gastroenterol. 2010; 44 (2): 153–4. DOI: 10.1097/MCG.0b013e3181aae531.

110. Steer ML, Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med. 1987; 316 (3): 144–50. DOI: 10.1056/NEJM198701153160306.

111. Остроумова О.Д., Качан В.О. Лекарственно-индуцированный панкреатит. Лечебное дело. 2020; 3: 14–25. DOI: 10.24412/2071–5315–2020–12251.


Рецензия

Для цитирования:


Филиппова А.В., Павлеева Е.Е., Остроумова О.Д. Лекарственные препараты, прием которых ассоциирован с развитием лекарственно-индуцированного панкреатита: фокус на редко обсуждаемые классы препаратов. Медицинский алфавит. 2021;1(29):33-39. https://doi.org/10.33667/2078-5631-2021-29-33-39

For citation:


Filippova A.V., Pavleeva E.E., Ostroumova O.D. Drugs associated with drug-induced pancreatitis: focus on rarely discussed drugs. Medical alphabet. 2021;1(29):33-39. (In Russ.) https://doi.org/10.33667/2078-5631-2021-29-33-39

Просмотров: 76


ISSN 2078-5631 (Print)